Cargando…
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
Through whole-transcriptome profiling of HER2+ breast carcinomas (BCs), we previously showed that those sensitive to trastuzumab are addicted to this oncoprotein and are enriched in immune pathways, raising the hypothesis that HER2 itself regulates immune cell recruitment. In the present study we in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287794/ https://www.ncbi.nlm.nih.gov/pubmed/30546951 http://dx.doi.org/10.1080/2162402X.2018.1512942 |